Intratumoral mRNA Approach to Delivering Cytokine Immunotherapies

Time: 2:00 pm
day: Day One

Details:

  • Comparison to other approaches
  • MEDI1191: IL12 mRNA mechanism of action and preclinical data
  • Update of clinical, safety, and translational data from ongoing first-in-human clinical trial in combination with durvalumab

Speakers: